SHENZHEN, China, Dec. 27, 2010 /PRNewswire-Asia-FirstCall/ —
Mindray Medical International Limited (NYSE:
MR), a leading developer, manufacturer and marketer of medical
devices worldwide, today announced shareholder resolutions adopted
at its annual general meeting of shareholders held in Hong Kong on
December 22, 2010.
At the meeting, Mindray shareholders approved the re-election of
incumbent directors Ms. Joyce I-Yin Hsu and Mr. Wu Qiyao, each to
serve a three-year term.
In addition, Mindray shareholders ratified the appointment of
PricewaterhouseCoopers as the company’s independent registered
public accounting firm for the fiscal year ending December 31,
2010.
About Mindray
We are a leading developer, manufacturer and marketer of medical
devices worldwide. We maintain global headquarters in Shenzhen,
China, U.S. headquarters in Mahwah, New Jersey and multiple sales
offices in major international markets. From our main manufacturing
and engineering base in China and through our worldwide
distribution network, we are able to supply internationally a broad
range of products across three primary business segments, comprised
of patient monitoring and life support products, in-vitro
diagnostic products and medical imaging systems. For more
information, please visit http://www.mindray.com. For
investor and media inquiries please contact:In the U.S.:Hoki
Luk
Western Bridge, LLC
Tel: +1-646-808-9150
Email:
hoki.luk@westernbridgegroup.comIn China:Cathy Gao
Mindray Medical International Limited
Tel: +86-755-2658-2620
Email:
cathy.gao@mindray.com
‘/>”/>
SOURCE
